Previous research also found the drug cuts the risk of stroke, heart attack or death due to cardiovascular disease by 20% in those who are obese or overweight, leading the FDA to approve semaglutide for cardiovascular management in those with higher BMIs
Heres how to maintain your success: Maintain Healthy Habits: Continue the healthy lifestyle practices developed during Semaglutide GLP-1 treatment, including mindful eating and regular physical activity
Fat loss support Growth hormone assists fat breakdown (lipolysis) and metabolic efficiency, helping reduce body fat especially when paired with training and diet
BP, glycemic parameters and lipids were measured at randomization, every 4 weeks to week 24, then at weeks 32, 44, 52, 64, 76, 88, 100 and 104
Because PT-141 acts centrally rather than via the vasculature, some providers may use it alongside other treatments when appropriate